LZVO Newsletter

The European Medicines verification organization (EMVO) has prepared an overview of the fee models of the national medicines verification organizations...

LZVO informs that the temporary technical issues detected on March 3 have been resolved and the operation of the LZVS has been fully restored.

LZVO informs that on Tuesday, March 3, technical issues were detected in the operation of the Latvian Medicines Verification System.

This newsletter provides information on the 2025 performance indicators of the Latvian Medicines Verification System, as well as an evaluation of LZVO’s customer service and IT suppliers.

Latvijas Zāļu verifikācijas organizācija (LZVO) informē, ka 2026.gada 22.janvāra rītā veiksmīgi noslēgusies LZVS digitālās infrastruktūras pāreja uz “Oracle EU Sovereign...

To improve service quality and strengthen cooperation, the LZVO conducted its regular end-user survey on LZVO customer service in December 2025.